Showing results (2961-2970 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|March 17, 2001
Cost efficacy of tazobactam/piperacillin versus imipenem/cilastatin in the treatment of intra-abdominal infectionE S Dietrich, B Schubert, W Ebner, et al.Pharmacoeconomics|November 11, 1999
Cost effectiveness of Helicobacter pylori eradication therapies in patients with duodenal ulcer. An analysis of triple therapy versus two dual therapy alternativesG R Tennvall, A Norinder, B OhlinPharmacoeconomics|November 11, 1999
Decreased medical expenditures for care of HIV-seropositive patients. The impact of highly active antiretroviral therapy at a US Veterans Affairs Medical CenterL Mole, K Ockrim, M HolodniyPharmacoeconomics|March 21, 2000
Diagnosis and management of osteomyelitis. Decision analytic and pharmacoeconomic considerationsM Tavakoli, P Davey, B A Clift, et al.Pharmacoeconomics|July 18, 2001
An economic overview of chronic obstructive pulmonary diseaseH S Ruchlin, E J DasbachPharmacoeconomics|November 10, 2001
The cost of palliative care for hepatocellular carcinoma in Hong KongA T Chan, P Jacobs, W Yeo, et al.Pharmacoeconomics|November 10, 2001
Using health outcomes data to inform decision-making: government agency perspectiveR TaylorPharmacoeconomics|July 24, 2001
The cost effectiveness of tapered versus abrupt discontinuation of oral cyclosporin microemulsion for the treatment of psoriasisL Hakkaart-van Roijen, P Verboom, W K Redekop, et al.Pharmacoeconomics|January 9, 2001
Cost effectiveness of abciximab during routine medical practiceS O Reed, C D Mullins, L S MagderPharmacoeconomics|January 9, 2001
The economic value of a new insulin preparation, Humalog Mix 25. Measured by a willingness-to-pay approachG Dranitsaris, C J Longo, L D GrossmanPageof 336